Forex
World
Market
Business
Cryptocurrency
Commodities
MAP
Publish for free
Business
financetom
/
Business
/
US FDA approves Amgen drug for small cell lung cancer, Bloomberg News reports
News
World
Market
Environment
Technology
Personal Finance
Politics
Retail
Business
Economy
Cryptocurrency
Forex
Stocks Market
Commodities
US FDA approves Amgen drug for small cell lung cancer, Bloomberg News reports
May 16, 2024 12:29 PM
Previous page:
Top Premarket Decliners
Next page:
--Bain Capital to Acquire PowerSchool in $5.6 Billion Deal
Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Release time ⇩
Release time ⇧
Like count ⇩
Show More Comments
Related Articles >
Top Premarket Decliners
Jun 7, 2024
07:49 AM EDT, 06/07/2024 (MT Newswires) -- Biomea Fusion ( BMEA ) shares slumped 61% Friday premarket after the company said that the US Food and Drug Administration placed a full clinical hold on the company's diabetes program. Logistic Properties of the Americas ( LPA ) fell 17%, paring Thursday's rally. Processa Pharmaceuticals ( PCSA ) shares retreated 16% following...
--Bain Capital to Acquire PowerSchool in $5.6 Billion Deal
Jun 7, 2024
07:48 AM EDT, 06/07/2024 (MT Newswires) -- Price: 22.48, Change: +0.11, Percent Change: +0.49 ...
GameStop's first-quarter sales drop as company releases results early
Jun 7, 2024
(Reuters) -GameStop ( GME ) reported a drop in first-quarter net sales and announced a more than $3 billion stock offer as it released its quarterly report early, sending the video games retailer's shares down 10% before the bell on Friday. The company was scheduled to post results on June 11, but instead published its quarterly figures on Friday morning,...
GameStop Releases Q1 Results Ahead Of 'Roaring Kitty' Event, Files Prospectus To Raise Capital Via Equity Offering
Jun 7, 2024
Video game retailer GameStop Corp ( GME ) stock released its first-quarter 2024 results early Friday ahead of its scheduled June 11 date. The company reported net sales of $881.8 million, down from $1.237 billion year-over-year. The net sales total missed a consensus estimate of $995.3 million. The company reported a loss of 12 cents per share, missing the estimate...
About
Terms and Conditions
Privacy policy
Cookie Settings
Contact Us
Services
Login
register
financetom
Market
Personal Finance
Business
Economy
Cryptocurrency
MAP
Links
zpostcode
Recruit
weather
mreligion
Yellowpages
sport
constellation
shopping
name
game
directory
literature
Word
tour
furnish
Lottery
tftnews
lyrics
News
digital
car
dir
Edu
Finance
Copyright 2023-2026 -
www.financetom.com
All Rights Reserved
News
World
Market
Environment
Technology
Personal Finance
Politics
Retail
Business
Economy
Cryptocurrency
MAP